Ask AI

Lung Cancer

For coverage of lymphoma and leukemia at ASCO and EHA 2026, click here.

Share

Program Content

Activities

  • IMforte Subtype and QTWiST Analyses
    IMforte Phase III Trial: Transcriptomic and Q-TWiST Analyses of Lurbinectedin + Atezolizumab Maintenance Therapy in Extensive-Stage SCLC
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 22, 2026

  • DeLLphi-304 Intracranial Efficacy
    DeLLphi-304 Phase III Trial: Post Hoc Analysis of Intracranial Efficacy of Tarlatamab vs Chemotherapy as Second-line Treatment for SCLC
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 24, 2026

  • LIBRETTO-432
    LIBRETTO-432: Phase III Trial of Adjuvant Selpercatinib in Stage IB-IIIA RET Fusion–Positive NSCLC
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 15, 2026

  • HARMONi 6 OS
    HARMONi-6 Phase III Trial: OS Outcomes With 1L Ivonescimab + Chemotherapy vs Tislelizumab + Chemotherapy for Advanced Squamous NSCLC
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 24, 2026

  • WU KONG28
    WU-KONG28: Phase III Trial of First-line Sunvozertinib vs Platinum-Based Chemotherapy in Advanced NSCLC With EGFR Exon 20 Insertion Mutations
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 24, 2026

  • Lung Cancer Highlights From ASCO 2026
    Lung Cancer Highlights From ASCO 2026: Expert Perspectives on Emerging Practice-Changing Data
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: July 31, 2026

    Expires: January 30, 2028

Supporters

This activity is supported by educational grants from Lilly and PharmaMar.

Lilly

PharmaMar